NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 44 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136,482 | +30.8% | 92,000 | +12.2% | 0.00% | – |
| Q2 2023 | $104,345 | +12.7% | 82,000 | +18.8% | 0.00% | – |
| Q1 2023 | $92,564 | -55.2% | 69,000 | -47.3% | 0.00% | – |
| Q4 2022 | $206,522 | -6.6% | 131,000 | -26.0% | 0.00% | – |
| Q4 2021 | $221,000 | -49.1% | 177,000 | -45.9% | 0.00% | – |
| Q3 2021 | $434,000 | +1396.6% | 327,000 | +1386.4% | 0.00% | – |
| Q2 2021 | $29,000 | +3.6% | 22,000 | +4.8% | 0.00% | – |
| Q1 2021 | $28,000 | -75.2% | 21,000 | -74.4% | 0.00% | – |
| Q4 2020 | $113,000 | +175.6% | 82,000 | +173.3% | 0.00% | – |
| Q3 2020 | $41,000 | +24.2% | 30,000 | +50.0% | 0.00% | – |
| Q2 2020 | $33,000 | +22.2% | 20,000 | -4.8% | 0.00% | – |
| Q1 2020 | $27,000 | -15.6% | 21,000 | 0.0% | 0.00% | – |
| Q4 2019 | $32,000 | -87.3% | 21,000 | -88.6% | 0.00% | – |
| Q3 2019 | $252,000 | -78.0% | 184,000 | -80.8% | 0.00% | -100.0% |
| Q4 2018 | $1,144,000 | – | 958,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CSS LLC/IL | 15,659,000 | $23,207,687 | 1.52% |
| SONA ASSET MANAGEMENT (US) LLC | 17,500,000 | $26,317,952 | 1.09% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 26,765,000 | $40,113,099 | 0.86% |
| Warberg Asset Management LLC | 1,271,000 | $1,885,846 | 0.38% |
| SSI INVESTMENT MANAGEMENT LLC | 2,296,000 | $3,406,116 | 0.28% |
| Paloma Partners Management Co | 3,125,000 | $4,694,590 | 0.16% |
| FRANKLIN RESOURCES INC | 54,750,000 | $81,769,125 | 0.04% |
| Rock Springs Capital Management LP | 1,000,000 | $1,497,950 | 0.04% |
| LORD, ABBETT & CO. LLC | 4,666,000 | $6,922 | 0.03% |
| D. E. Shaw & Co., Inc. | 14,351,000 | $21,373,197 | 0.02% |